Phospho-VEGF Receptor 2 (Tyr1175) (D5B11) Rabbit mAb 3770S from Cell Signaling Technology

Product Specs
ItemPhospho-VEGF Receptor 2 (Tyr1175) (D5B11) Rabbit mAb
CompanyCell Signaling Technology
Price $401.00 Inquire
Catalog Number3770S
Quantity100 µl
ApplicationsW, IP
ReactivityH, M
TargetVEGFR2 (Tyr1175) phosphate
ModificationsVEGFR2 (Tyr1175) phosphate
HostRabbit
NCBI Gene AliasesCD309, FLK1, VEGFR, VEGFR2
ClonalityMonoclonal
NCBI Full Gene Namekinase insert domain receptor
Research AreaRTK
IsotypeIgG
CloneD5B11
Molecular Weight230

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) An Inhibitory Aptamer Against PDGF-C Overcomes Anti-VEGF Refractoriness and Reduces Choroidal Neovascularization and FibrosisInvest Ophthalmol Vis SciMay 15, 2026Rongyuan Chen, Weiwei Lu, Juanhua Zhu, Lijuan Huang, Wei Chen, Guanqun Huang, Xiangrong Ren, Qihang Sun, Jiaxin Hu, Jiani Li, et al.Cell Signaling Technology), phosphorylated ERK (pERK; 4370S; Cell Signaling Technology), phosphorylated VEGFR2 (pVEGFR2; 3770; Cell Signaling Technology), and VEGFR2 (9698; Cell Signaling Technology). The membranes were incubated

(2) Pre-Clinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case ReportCancer Research CommunicationsApril 1, 2026Nikolina Radulovich, Pamela Soberanis. Pina, Molly L. Udaskin, Quan Li, Kevin C.J. Nixon, Irene Y. Xie, Ankita Nand, Joshua C. Rosen, Ming Li, Anjelica Hodgson, et al.Cell Signaling Technology, cat. #9698, RRID: AB_11178792), anti-VEGFR2 pY1175 (1:500, Cell Signaling Technology, cat. #3770, RRID: AB_1642326), anti-ERK1/2 (1:2,000, Cell Signaling Technology, cat. #4695, RRID: AB_390779), anti-ERK1/2

(3) Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case ReportCancer Res CommunApril 1, 2026Nikolina Radulovich, Pamela Soberanis Pina, Molly L. Udaskin, Quan Li, Kevin C.J. Nixon, Irene Y. Xie, Ankita Nand, Joshua C. Rosen, Ming Li, Anjelica Hodgson, et al.Cell Signaling Technology, cat. #9698, RRID: AB_11178792), anti-VEGFR2 pY1175 (1:500, Cell Signaling Technology, cat. #3770, RRID: AB_1642326), anti-ERK1/2 (1:2,000, Cell Signaling Technology, cat. #4695, RRID: AB_390779), anti-ERK1/2

(4) Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodyniaBioact MaterMarch 4, 2026Xiaobin Luo, Toshitatsu Nagayasu, Yuhao Zhang, Zhi He, Jia Yang, Chengli Li, Guman Duan, Qunchuan Zong, Yun Liu, Kaiyuan Yang, et al.sc-376495), anti-VEGF-A (Cell Signaling Technology, #50661), anti-phospho-VEGFR2 (Cell Signaling Technology, #3770), and anti-β-actin (Abcam, ab6276). After washing, membranes were incubated with HRP-conjugated secondary

(5) Identification of a small molecule that targets activator of G-protein signaling 8The Journal of Physiological SciencesMarch 1, 2026Alamgir Hossain, Aya Yamamura, Rie Takahashi, Takashi Iezaki, Hisaki Hayashi, Hiroyuki Hirano, Hiroyuki Osada, Kazuo Umezawa, Motohiko Satocells. Materials and methods Materials Antibodies against VEGFR2 (#2479), phospho-VEGFR2 (Tyr1175) (#3770), p38MAPK family proteins (#9212), phospho-p38 MAPK family proteins (Thr180/Tyr182) (#9211), ERK1/2

(6) Thyroid Hormone T4 Alleviates Traumatic Brain Injury by Enhancing Blood-Brain Barrier IntegrityInt J Mol SciOctober 3, 2025Mayuri Khandelwal, Zhe Ying, Fernando Gomez-Pinilla(Danvers, MA, USA)",13667,92 TLR-4,"Santa Cruz (Dallas, TX, USA)",sc-293072,95 pVEGFR2,Cell signaling,3770,230 VEGFR2,Cell signaling,9698,210 and 230 ZO-1,Cell signaling,8193,220 OXPHOS,"Invitrogen (Carlsbad,

(7) MTOR maintains endothelial cell integrity to limit lung vascular injuryJournal of Biological ChemistryDecember 1, 2024Michelle Warren Millar, Rauf A. Najar, Spencer A. Slavin, Mohammad Shadab, Imran Tahir, Zahra Mahamed, Xin Lin, Jun-ichi Abe, Terry W. Wright, David A. Dean, et al.ALI. Experimental procedures Reagents Antibodies to MTOR (2983S), VEGFR2 (9698S), phospho-VEGFR2Y1175 (3770S), phospho-VEGFR2Y1059 (3817S), phospho-ENOSS1177 (9571S), eNOS (32027S), phospho-AKTS473 (4060S), AKT

(8) CPT1A mediates radiation sensitivity in colorectal cancerElifeNovember 28, 2024Zhenhui Chen, Lu Yu, Zhihao Zheng, Xusheng Wang, Qiqing Guo, Yuchuan Chen, Yaowei Zhang, Yuqin Zhang, Jianbiao Xiao, Keli Chen, et al.,Cell Signaling Technology (USA),12252, Antibody,β-Actin (8H10D10) Mouse mAb,Cell Signaling Technology (USA),3770, Antibody,Mouse anti-Ki67 monoclonal antibody,Cell Signaling Technology (USA),9449, Antibody,PPARA

(9) CPT1A mediates radiation sensitivity in colorectal cancereLifeNovember 28, 2024Zhenhui Chen, Lu Yu, Zhihao Zheng, Xusheng Wang, Qiqing Guo, Yuchuan Chen, Yaowei Zhang, Yuqin Zhang, Jianbiao Xiao, Keli Chen, et al.,Cell Signaling Technology (USA),12252, Antibody,β-Actin (8H10D10) Mouse mAb,Cell Signaling Technology (USA),3770, Antibody,Mouse anti-Ki67 monoclonal antibody,Cell Signaling Technology (USA),9449, Antibody,PPARA

(10) Ganglion cell-derived LysoPS induces retinal neovascularisation by activating the microglial GPR34-PI3K-AKT-NINJ1 axisJournal of neuroinflammationOctober 28, 2024Chen L, Zhang H, Zhang Y, Li X, Wang M, Shen Y, Cao Y, Xu Y, Yao J.rabbit anti-VEGFA (1:1000, 50661), rabbit anti-VEGFR2 (1:1000, 2479), rabbit anti-pVEGFR2 (1:1000, 3770), rabbit anti-STAT3 (1:1000, 9139), rabbit anti-pSTAT3 (1:1000, 9145), and mouse anti-βactin (1:1000,

(11) MMPP is a novel VEGFR2 inhibitor that suppresses angiogenesis via VEGFR2/AKT/ERK/NF-κB pathwayBMB ReportsMay 31, 2024Na-Yeon Kim, Hyo-Min Park, Jae-Young Park, Uijin Kim, Ha Youn Shin, Hee Pom Lee, Jin Tae Hong, Do-Young Yoonprimary antibodies (1:1,000) were incubated for 1 h. The primary antibodies were used against p-VEGFR2 (#3770s), VEGFR2 (#2472s), and p-ERK (#9101s) (Cell Signaling Technology, MA, United States), p65 (#4764s),

(12) MMPP is a novel VEGFR2 inhibitor that suppresses angiogenesis via VEGFR2/AKT/ERK/NF-κB pathwayBMB RepFebruary 19, 2024Na-Yeon Kim, Hyo-Min Park, Jae-Young Park, Uijin Kim, Ha Youn Shin, Hee Pom Lee, Jin Tae Hong, Do-Young Yoonprimary antibodies (1:1,000) were incubated for 1 h. The primary antibodies were used against p-VEGFR2 (#3770s), VEGFR2 (#2472s), and p-ERK (#9101s) (Cell Signaling Technology, MA, United States), p65 (#4764s),

(13) Cyb5r3 activation rescues secondary failure to sulfonylurea but not β-cell dedifferentiationPloS oneJanuary 1, 2024Watanabe H, Asahara SI, Son J, McKimpson WM, de Cabo R, Accili D.Technology, Danvers, MA). We used anti-Aldh1a3 (NBP2-15339; Novus Biologicals) and anti-β-actin antibodies (#3770, Cell Signaling Technology) for immunoblotting, and Odyssey imaging system (LI-COR, Lincoln, NE) to

(14) A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses AngiogenesisMarine DrugsSeptember 28, 2023Nannan Song, Yanfei Tang, Yangui Wang, Xian Guan, Wengong Yu, Tao Jiang, Ling Lu, Yuchao GuVEGFR2 (1:1000, Cell Signaling Technology, Cat#9698), p-VEGFR2 (1:1000, Cell Signaling Technology, Cat#3770), Histone H3 (1:2000, Cell Signaling Technology, Cat#9715S), AKT (1:1000, Cell Signaling Technology,

(15) SAIF plays anti-angiogenesis via blocking VEGF-VEGFR2-ERK signal in tumor treatmentHeliyonJuly 14, 2023Junye Xie, Fu Li, Yuling Cai, Jinting Zhang, Yibo Zhang, Zhaodong Zhai, Zijian Su, Xue Chen, Minghua Lei, Rongzhan Liu, et al.#ab76299), anti-ERK1/2 (CST, Cat. #9102), anti-VEGFR2 (CST, Cat. #9698), anti-phospho-VEGFR2 (CST, Cat. #3770). 2.15 Molecular docking Alphafold software [29] was used to model the peptides based on MSA multiple

(16) Targeting RAF Isoforms and Tumor Microenvironments in RAS or BRAF Mutant Colorectal Cancers with SJ-C1044 for Anti-Tumor ActivityCurrent issues in molecular biologyJuly 13, 2023Hong S, Jeon M, Kwon J, Park H, Lee G, Kim K, Ahn S.#2232S), phosphorylated vascular endothelial growth factor receptor (p-VEGFR, Cell Signaling Technology #3770S), vascular endothelial growth factor receptor (VEGFR, Cell Signaling Technology #2479S), phosphorylated

(17) PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancerAgingJuly 3, 2023Zheng Y, Ji H, Yi W, Chen Z, Hu X, Zhou J, Wang Y, Zheng X.(Cell Signaling Technology, cat# 36169), Phospho-Tyr1175-VEGF Receptor 2 (Cell Signaling Technology, cat# 3770), phospho-Tyr996-VEGF Receptor 2 (Cell Signaling Technology, cat# 2474), total VEGFR 2 (Cell Signaling Technology

(18) Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical ModelsJournal of Hepatocellular CarcinomaMarch 27, 2023Mingxun Wang, Xinfei Yao, Zhiyuan Bo, Jiuyi Zheng, Haitao Yu, Xiaozai Xie, Zixia Lin, Yi Wang, Gang Chen, Lijun WuAF,1015S), anti-RET (1:1000, CST, 14556S), anti-p-RET (1:1000, CST, 3221S), anti-p-VEGFR2 (1:1000, CST, 3770S), anti-VERGFR2 (1:1000, CST, 2479S), and anti-GAPDH (1:5000, Sigma, G9545). Histological and Immunohistochemical

(19) Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical ModelsJ Hepatocell CarcinomaMarch 27, 2023Mingxun Wang, Xinfei Yao, Zhiyuan Bo, Jiuyi Zheng, Haitao Yu, Xiaozai Xie, Zixia Lin, Yi Wang, Gang Chen, Lijun WuAF,1015S), anti-RET (1:1000, CST, 14556S), anti-p-RET (1:1000, CST, 3221S), anti-p-VEGFR2 (1:1000, CST, 3770S), anti-VERGFR2 (1:1000, CST, 2479S), and anti-GAPDH (1:5000, Sigma, G9545). Histological and Immunohistochemical

(20) VEGF Stimulates Activation of ERK5 in the Absence of C-Terminal Phosphorylation Preventing Nuclear Localization and Facilitating AKT Activation in Endothelial CellsCellsMarch 22, 2023Anil Kumar Mondru, Mohammad A. Aljasir, Ahmed Alrumayh, Gopika N. Nithianandarajah, Katie Ahmed, Jurgen Muller, Christopher E. P. Goldring, Bettina Wilm, Michael J. CrossT202/Y204 (#4370), phospho-ERK5 T218/Y220 (#3371), phospho-EGFR1 Y1061 (#3777), phospho-VEGFR2 Y1175 (#3770), phospho-p38 MAPK T180/Y182 (#4631), phospho-MAPKAPK2 Thr334 (#3007) were purchased from Cell Signalling

Be the First to Write a Review!

Phospho-VEGF Receptor 2 (Tyr1175) (D5B11) Rabbit mAb

Phospho-VEGF Receptor 2 (Tyr1175) (D5B11) Rabbit mAb from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (67)

Reviews

Phospho-VEGF Receptor 2 (Tyr1175) (D5B11) Rabbit mAb from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map